ProfileOfResearchers

TÃTULO: Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial
AUTORES: Michinori Ogura; Juan Manuel Sancho; Seok Goo Cho; Hideyuki Nakazawa; Junji Suzumiya; Gayane Tumyan; Jin Seok Kim; Anne Lennard; Jose Mariz; Nikolai Ilyin; Wojciech Jurczak; Aurelio Lopez Martinez; Olga Samoilova; Edvard Zhavrid; Eduardo Yanez Ruiz; Marek Trneny; Leslie Popplewell; Bertrand Coiffier; Christian Buske; Woo Seog Kim; Sang Joon Lee; Sung Young Lee; Yun Ju Bae; Larry W Kwak; ...Mais
PUBLICAÇÃO: 2018, FONTE: LANCET HAEMATOLOGY, VOLUME: 5, NÚMERO: 11

INDEXADO EM:

Scopus

WOS

TÃTULO: Therapeutic options in relapsed or refractory peripheral T-cell lymphoma Full Text
AUTORES: Bertrand Coiffier; Massimo Federico; Dolores Caballero; Claire Dearden; Franck Morschhauser; Ulrich Jaeger; Lorenz Truemper; Emanuele Zucca; Maria Gomes da Silva; Ruth Pettengell; Eckhart Weidmann; Francesco d'Amore; Herve Tilly; Pier Luigi Zinzani;
PUBLICAÇÃO: 2014, FONTE: CANCER TREATMENT REVIEWS, VOLUME: 40, NÚMERO: 9

INDEXADO EM:

WOS

TÃTULO: Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib-Rituximab Versus Rituximab
AUTORES: Bertrand Coiffier; Weimin M Li; Erin D Henitz; Jayaprakash D Karkera; Reyna Favis; Dana Gaffney; Alice Shapiro; Panteli Theocharous; Yusri A Elsayed; Helgi van de Velde; Michael E Schaffer; Evgenii A Osmanov; Xiaonan N Hong; Adriana Scheliga; Jiri Mayer; Fritz Offner; Simon Rule; Adriana Teixeira; Joanna Romejko Jarosinska; Sven de Vos; Michael Crump; Ofer Shpilberg; Pier Luigi Zinzani; Andrew Cakana; Dixie Lee Esseltine; George Mulligan; Deborah Ricci; ...Mais
PUBLICAÇÃO: 2013, FONTE: CLINICAL CANCER RESEARCH, VOLUME: 19, NÚMERO: 9

INDEXADO EM:

Scopus

WOS

TÃTULO: A Randomized Study of Interferon alpha-2b Versus No Treatment as Consolidation After High Dose Therapy and Autologous Stem Cell Transplantation for Patients With Relapsed Lymphoma
AUTORES: Andre Bosly; Andrew Grigg; Harald Holte; Christian Gisselbrecht; John Radford; Andrea Rossi; Armando Lopez Guillermo; Marek Trneny; Catherine Sebban; Hans Hagberg; Fernando Leal da Costa; Philippe Colombat; Dominique Bron; Bertrand Coiffier;
PUBLICAÇÃO: 2013, FONTE: ONCOLOGIST, VOLUME: 18, NÚMERO: 11

INDEXADO EM:

Scopus

WOS

TÃTULO: Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study
AUTORES: Bertrand Coiffier; Weimin M Li; Erin D Henitz; Karkera, JD; Reyna Favis; Dana Gaffney; Alice Shapiro; Panteli Theocharous; Yusri A Elsayed; Helgi van de Velde; Evgenii A Osmanov; Xiaonan N Hong; Adriana Scheliga; Fritz C Offner; Simon Rule; Adriana C Teixeira; Jan Walewski; Sven de Vos; Michael Crump; Ofer Shpilberg; Pier Luigi Zinzani; Andrew Z Cakana; Dixie Lee Esseltine; George Mulligan; Deborah S Ricci; ...Mais
PUBLICAÇÃO: 2011, FONTE: 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis in BLOOD, VOLUME: 118, NÚMERO: 21

INDEXADO EM:

WOS

INDEXADO EM:

Scopus

WOS

TÃTULO: A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma
AUTORES: Bertrand Coiffier; Evgenii Osmanov; Xiaonan N Hong; Adriana Scheliga; Jiri Mayer; Fritz C Offner; Simon A Rule; Adriana Teixeira; Jan A Walewski; Michael Crump; Ofer Shpilberg; Robert Hermann; Sudha Parasuraman; Eugene Zhu; Christopher Enny; Panteli Theocharous; Helgi van de Velde; Yusri Elsayed; Pier Luigi Zinzani;
PUBLICAÇÃO: 2010, FONTE: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 116, NÚMERO: 21

INDEXADO EM:

WOS

Links Úteis